Company / Cash per Share
PUMA BIOTECHNOLOGY, INC. Cash per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.60
FY2025
5-year range
$0.60 / $1.85
FY2021-FY2025
Trend
-58.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has declined for 3 consecutive years, from $1.85 in FY2022 to $0.60 in FY2025.
Based on SEC 10-K filings.
0.60 in FY2025 with a 5-year CAGR of -22.6%.
Declined from $1.83 to $0.60 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -31.2%
- 5-Year CAGR
- -22.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- PUMA BIOTECHNOLOGY, INC.'s cash per share has declined for 3 consecutive years.
- In FY2025, cash per share decreased 58.5% year-over-year.
- Peak cash per share was recorded in FY2018.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.60 | -58.5% |
| FY2024 | $1.45 | -20.4% |
| FY2023 | $1.83 | -1.4% |
| FY2022 | $1.85 | +17.5% |
| FY2021 | $1.57 | -27.6% |
| FY2020 | $2.18 | +38.9% |
| FY2019 | $1.57 | -45.7% |
| FY2018 | $2.88 | +30.0% |
| FY2017 | $2.22 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026